IRF6 and neuroblastoma: In our study, we found that IRF6 directly interacted with the PGM1 promoter, inhibiting its transcription; subsequently, the downregulation of PGM1 inhibited glycolysis-mediated tumor cell proliferation in neuroblastoma, highlighting the role of PGM1 in facilitating the progression of neuroblastoma.